Jeffrey Oram's most recent trade in Alzamend Neuro Inc was a trade of 50,000 Restricted Stock Grant done . Disclosure was reported to the exchange on March 15, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Alzamend Neuro Inc | Jeffrey Oram | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 50,000 | 0 | - | - | Restricted Stock Grant | |
Alzamend Neuro Inc | Jeffrey Oram | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 50,000 | 100,000 | - | 0 | Common Stock |